Z, H., D, L., A, M., G, C., S, R., MB, A., . . . W, H. (2026). Outcomes Of Neoadjuvant Chemoradiation Vs Neoadjuvant Chemotherapy for Esophageal Junction Signet Ring Cell Adenocarcinoma. The Annals of thoracic surgery, 122(3), 732. https://doi.org/10.1016/j.athoracsur.2026.05.033
Chicago Style (17th ed.) CitationZ, Hooda, et al. "Outcomes Of Neoadjuvant Chemoradiation Vs Neoadjuvant Chemotherapy for Esophageal Junction Signet Ring Cell Adenocarcinoma." The Annals of Thoracic Surgery 122, no. 3 (2026): 732. https://doi.org/10.1016/j.athoracsur.2026.05.033.
MLA (9th ed.) CitationZ, Hooda, et al. "Outcomes Of Neoadjuvant Chemoradiation Vs Neoadjuvant Chemotherapy for Esophageal Junction Signet Ring Cell Adenocarcinoma." The Annals of Thoracic Surgery, vol. 122, no. 3, 2026, p. 732, https://doi.org/10.1016/j.athoracsur.2026.05.033.